Fig. 1: Effects of 188Re-liposome on different HNSCC cell lines using low dose and high dose. | Cell Death Discovery

Fig. 1: Effects of 188Re-liposome on different HNSCC cell lines using low dose and high dose.

From: PEGylated liposome-encapsulated rhenium-188 radiopharmaceutical inhibits proliferation and epithelial–mesenchymal transition of human head and neck cancer cells in vivo with repeated therapy

Fig. 1

a Change of cell morphology and amount in FaDu cells, SAS cells, and OECM-1 cells treated with low dose (100 μCi) and high dose (300 μCi) of 188Re-liposome. Scale bar: 100 μm. b Quantification of cell number in cells treated with low or high dose of 188Re-liposome. Data were represented as means ± S.D. *p < 0.05 by a t-test

Back to article page